Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,884.50
-43.00 (-2.23%)
Aug 28, 2025, 12:31 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 317.57 billion as of August 27, 2025. Its market cap has decreased by -4.93% in one year.
Market Cap
317.57B
Enterprise Value
291.18B
Revenue
57.20B
Ranking
n/a
PE Ratio
41.23
Stock Price
1,884.50
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 317.57B, an increase of 6.89%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 317.57B | 8.33% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
| Nov 20, 2020 | 297.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,974.98B |
| Divi's Laboratories | 1,658.78B |
| Cipla | 1,293.38B |
| Apollo Hospitals Enterprise | 1,128.85B |
| Mankind Pharma | 1,055.39B |
| Zydus Lifesciences | 1,029.53B |
| Fortis Healthcare | 690.90B |
| Alkem Laboratories | 647.50B |